Nanologica: Resuming coverage and preview of Q3 - Redeye

Redeye resumes coverage of Nanologica following the announced outcome of its rights issue, which secures approximately SEK76.5m in net proceeds for the company. We have updated our estimates in light of recent newsflow in preparation for the Q3 report, scheduled for November 8th.

Länk till analysen i sin helhet: https://www.redeye.se/research/1048802/nanologica-resuming-coverage-and-preview-of-q3?utm_source=finwire&utm_medium=RSS